BioNTech SE (BNTX) Enterprise Value Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.27% |
| Sep 30, 2025 | 16.51% |
| Jun 30, 2025 | 21.08% |
| Mar 31, 2025 | 27.79% |
| Dec 31, 2024 | 1.08% |
| Sep 30, 2024 | -15.19% |
| Jun 30, 2024 | -20.38% |
| Mar 31, 2024 | -29.07% |
| Dec 31, 2023 | -40.67% |
| Sep 30, 2023 | -88.84% |
| Jun 30, 2023 | -152.52% |
| Mar 31, 2023 | -690.51% |
| Dec 31, 2022 | -504.70% |
| Sep 30, 2022 | -563.22% |
| Jun 30, 2022 | -351.68% |
| Mar 31, 2022 | 100.00% |
| Dec 31, 2021 | -47.71% |
| Dec 31, 2020 | -178.69% |
| Dec 31, 2019 | -22.88% |
| Sep 30, 2019 | -157.73% |